메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Angel Yeast Cup Finals and Industry Development Conference Concludes

Engaging the World Through Fermented Flour-Based Foods SHANGHAI, Aug. 22, 2025 -- The Finals of the 8th Angel Yeast Cup Chinese Fermented Dim Sum Contest and the 12th Fermented Flour-Based Food Industry Development Conference wrapped up in Ningxiang, Hunan province, a region widely recognized as the birthplace of Chinese staple foods. Sponsored and organized by Angel Yeast Co., Ltd. (SH600298), the event brought together 26 youth teams from different countries and regions alongside leading experts, researchers, industry representatives, and skilled food artisans specializing in
- 김갑성 기자
- 2025-08-22 18:04
Heartbeats Launches Digital Wellness Platform Led by World-Renowned Heart Specialist Dr. Hosen Kiat

SYDNEY, Aug. 22, 2025 -- In an online world awash with wellness fads and misinformation, one of the world's most cited cardiologists has decided to step in. Dr Hosen Kiat, ranked among the top 1% of clinical researchers worldwide, has launched a YouTube channel dedicated to evidence-based advice on aging well — proving that age is no barrier to starting fresh. "For too long, social media has amplified hype and half-truths about health," Dr. Kiat said. "At 70, I want to show that prevention can be practical, reliable, and empowering — and that science, not specula
- 노기식 기자
- 2025-08-22 13:22
MALAYSIA SHOWCASES HEALTHCARE EXCELLENCE IN CAMBODIA, DRIVING MOMENTUM TOWARDS MYMT 2026

KUALA LUMPUR, Malaysia, Aug. 22, 2025 -- The Malaysia Healthcare Travel Council (MHTC) proudly presents Malaysia Healthcare Week 2025 in Phnom Penh, Cambodia, an initiative designed to strengthening healthcare ties between the two nations and position Malaysia as the medical tourism destination in the world. Taking place from 19 to 22 August 2025, the event features a series of engagements including medical sharing sessions, business-to-business (B2B) meetings, public outreach programmes, and networking events with Cambodian stakeholders, healthcare facilitators, and the expatr
- 김갑성 기자
- 2025-08-22 11:00
Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore

SINGAPORE, Aug. 22, 2025 -- Asia Bio Innovation Summit 2025 is one of the premier industry-focused events in Asia and focus on the hottest topics of ADC and CGT. Asia Bio Innovation summit 2025 Singapore brought together 30+ world-class Speakers, 10+ Exhibitors and 200+ Attendees from regulatory authority, big pharma, biotech, academia, CXO and etc, to harness the full potential of ADC and Cell & Gene Therapy across 2 days of content. Dual Engines of Innovation: ADC and CGT Drive Global Collaboration The summit spotlighted antibody-drug conjugates (ADCs) and cell and
- 김갑성 기자
- 2025-08-22 09:55
Orange Biomed Lands on Fortune Korea's Top 40 with Portable Diabetes Test

SEATTLE, Aug. 22, 2025 -- Orange Biomed, developer of the world's first pocket-sized A1C testing device, is receiving international recognition for its breakthrough microfluidic technology designed to enhance accessibility and accuracy in chronic disease management. The company has been selected for inclusion in Fortune Korea's "Top 40 Emerging South Korean Healthcare Innovations", highlighting its growing momentum in the U.S. healthcare market. The company's flagship product, the OBM rapid A1C, is the first portable device to measure glycated hemoglobin (A1C) using m
- 김갑성 기자
- 2025-08-22 00:00
Doceree launches Premium Programmatic adding more context, more reach, and more formats to traditional HCP programmatic

With Premium Programmatic, pharma marketers can now engage physicians across 2,000+ integrated specialist medical platforms delivering clinically aligned content at scale with unmatched precision and exclusive formats. SHORT HILLS, N.J., Aug. 21, 2025 -- Doceree, the only AI-powered operating system for healthcare marketing, today announced the launch of Premium Programmatic—a significant step forward in HCP programmatic advertising. The platform redefines how life sciences brands can activate the reading layer of the HCP journey—a critical point where physicians consume c
- 김갑성 기자
- 2025-08-21 21:32
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment

Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. JENA, Germany, Aug. 21, 2025 -- ZEISS Medical Technology today announced CE mark approval for CIRRUS® PathFinder™, an innovative clinical support tool with artificial intelligence (AI) fully integrated to enable more confident decision-making and accelerate a clinician's workflow with OCT interpretation assistance. ZEISS CIRRUS PathFinder1 uses proprietary deep learning algorithms to automatically identify abnorm
- 김갑성 기자
- 2025-08-21 20:00
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to Korea. Both reviews expanded cooperation, including next-generation preventive medicines. SEONGNAM, South Korea, Aug. 21, 2025 -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the company held an exclusive meeting with the Gates Foundation in line with the visit of Bill Gates, Founder and Chair of the Foundation, to Korea to discuss ways to advance global health collaboration.&nbs
- 김갑성 기자
- 2025-08-21 20:00
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization

Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Control (BPOM), following Nigeria, Pakistan, and Colombia – accelerating global commercialization Approval in ASEAN's largest pharma market strengthens BioDlink's position as a global supplier of antibody/XDC therapies via international GMP standards and commercial capabilities SUZHOU, China, Aug. 21, 2025 -- BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Control (BPOM). This mark
- 김갑성 기자
- 2025-08-21 20:00
FDA clearance of Salix® Coronary Plaque module

[ 메디채널 김갑성 기자 ] Significantly expands U.S. commercial opportunity with ability to charge fees per scan assessed Investor Webinar - 11.30am AEST (9.30am AWST) on 22 August 2025 PERTH, Australia, Aug. 21, 2025 -- Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology company commercialising its Salix® AI-powered cloud platform, for the near real time, point of care assessment and management of coronary artery disease, is pleased to announce it has received 510(k) clearance from the U.S. Food and Drug Administration (the FDA) for Artrya's proprietary, Salix&r
- 김갑성 기자
- 2025-08-21 19:43

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 05일 13시 00분